Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Category: Pharma applications

May 13, 2026 Drug delivery / Environmental / Food / Uncategorized

Structural diversity of cyclodextrin metal-organic frameworks enables their diverse applications

Cyclodextrin-based metal-organic frameworks (CD-MOFs) constitute a distinctive family of porous solids that combine the modularity of coordination networks with the

Continue reading

May 12, 2026 Drug delivery / Pharma applications

Exploring Cyclodextrin-Based MOFs for Drug Delivery: Synthesis, Applications, and Future Perspectives

3D cyclodextrin-based metal-organic frameworks (CD-MOFs) have emerged as a biocompatible alternative to conventional MOFs, as they are synthesized using safer,

Continue reading

May 11, 2026 CD as API / CD derivatives / Drug delivery / Pharma applications

Sugammadex analog water soluble BCD polymer for peptide complexes

In this work, an integrated biophysical and biological study is presented describing both the structural and biological features of the

Continue reading

May 7, 2026 CD as API / Pharma applications / Uncategorized

Sugammadex vs Neostigmine: Effects on Obese Patients’ Recovery

Compared with neostigmine, sugammadex promotes faster neuromuscular recovery, but its impact on diaphragmatic function and respiratory recovery in the morbidly

Continue reading

May 6, 2026 CD derivatives / Drug delivery / Pharma applications / Uncategorized

Cyclodextrin-Amino Acid Conjugates

The scope of this review is to provide a comprehensive overview of the current synthetic methodologies for both mono- and

Continue reading

May 5, 2026 Drug delivery / Pharma applications / Uncategorized

Cyclodextrin complexation of selected tyrosine kinase inhibitors

The comprehensive physicochemical characterization and cyclodextrin complexation of four tyrosine kinase inhibitors — erlotinib, gefitinib, vandetanib, and lapatinib — were

Continue reading

April 27, 2026 CD derivatives / Drug delivery / Gene delivery / Pharma applications

Cationic Cyclodextrin-Based Carriers for Drug and Nucleic Acid Delivery

This review elaborates the recent developments in the cationic cyclodextrin-mediated delivery of drugs and nucleic acids. Cationic cyclodextrin-based delivery systems

Continue reading

April 24, 2026 CD derivatives / Non-pharma applications / Pharma applications

Special issue: “Synthesis, Analysis and Applications of Cyclodextrins and Their Derivatives”

Molecules (mdpi) invites the submission of original research papers and review articles concerning innovative synthetic pathways for new CD derivatives,

Continue reading

April 22, 2026 CD derivatives / Drug delivery / Pharma applications

Redox responsive cyclodextrin-based drug delivery systems: a special insight to glutathione responsive CD-nanosponges

Glutathione-responsive cyclodextrin nanosponges (CDNSs) exploit intracellular redox gradients via disulfide bond cleavage, enabling selective drug release in cancerous and inflammatory

Continue reading

April 21, 2026 Drug delivery / Pharma applications

CD in prevention of dengue-induced lethality

Annexin A1 (AnxA1) was identified as an endogenous regulator of inflammation in dengue. Treatment with the AnxA1 peptidomimetic, Ac2-26, improved

Continue reading

Posts pagination

«Previous Posts 1 2 3 4 5 … 129 Next Posts»

Recent Posts

  • Call for Chapters: Cyclodextrins for Next-Generation Electronics and Energy Storage
  • Call for Chapters: Cyclodextrins in Nutraceuticals 
  • Comparison of the siRNA and mRNA Carrying Capacity of Quaternary Ammonium β-Cyclodextrin Polymer and Polyethylenimine
  • Call for Chapters: Cyclodextrins in Phytomedicine
  • Poly-CD-PEG-camptothecin Combined with Olaparib  in People With Relapsed/​Refractory Small Cell Lung Cancer (Clinical trial)

Tags

alpha-CD Alzheimer disease atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (71)
  • CD as API (348)
  • CD derivatives (417)
  • Cosmetics and toilettry (52)
  • Diagnosis (13)
  • Drug delivery (798)
  • E-ducation (63)
  • Environmental (138)
  • Events (234)
  • Food (225)
  • Gene delivery (22)
  • Household products (5)
  • Household products (1)
  • In Hungarian (4)
  • Life sciences (43)
  • Non-pharma applications (403)
  • Other industrial use (109)
  • Pharma applications (1,191)
  • Supramolecular systems (42)
  • Uncategorized (153)

Top Posts

  • Call for Chapters: Cyclodextrins in Phytomedicine
  • Call for Chapters: Cyclodextrins in Nutraceuticals 
  • Poly-CD-PEG-camptothecin Combined with Olaparib  in People With Relapsed/​Refractory Small Cell Lung Cancer (Clinical trial)
  • Comparison of the siRNA and mRNA Carrying Capacity of Quaternary Ammonium β-Cyclodextrin Polymer and Polyethylenimine
  • Call for Chapters: Cyclodextrins for Next-Generation Electronics and Energy Storage
  • New FDA approved medicinal product containing Betadex sulfobutylether sodium: VYKOURA
  • GRAS status of CD derivatives
  • Cyclarity Unveils First-Ever Clinical Data Demonstrating Excretion of Oxidized Cholesterol, at American Heart Association Vascular Discovery Scientific Sessions
  • Citric acid cross-linked β-cyclodextrins: A review of preparation and environmental/biomedical application
  • A Cyclodextrin Surprise in a Japanese Supplement

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,474 other subscribers

Loading Comments...